|
Home Page
About Us
Investors
Inventors
Portfolio
3DR Laboratories, LLC
AllTranz Inc.
AnosiaVax, Inc.
ApoImmune, Inc.
EndoProtech, Inc.
Eyevation, LLC
ImmunoTheragnostics Incorporated
InnoRem, Inc.
Intrepid Bioinformatics, Inc.
PGxl Laboratories, LLC
Pradama Inc.
RhinoCyte, Inc.
TrackFive Diagnostics, Inc.
ULSD, LLC
Contact Us
Privacy Policy
|
|
|
|
Portfolio - AnosiaVax, Inc.
| Incorporated: |
|
1Q09
|
| Contacts: |
|
George N. Hajishengallis, Ph.D., Founder
|
| Description: |
|
AnosiaVax will develop safe and effective Tolllike Receptor-mediated vaccine adjuvants for stimulating immunity at mucosal surfaces. A provisional patent application, “Polypeptides and Their Use As Adjuvants,” was filed 1Q09 by UofL Research Foundation.
Company formed in partnership with MetaCyte, 1Q09
First collaboration with University of Louisville School of Dentistry
|
|
|
